BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27895313)

  • 1. Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-κB/GLUT1 axis.
    Jiang J; Geng G; Yu X; Liu H; Gao J; An H; Cai C; Li N; Shen D; Wu X; Zheng L; Mi Y; Yang S
    Oncotarget; 2016 Dec; 7(52):87271-87283. PubMed ID: 27895313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydroartemisinin inhibits glucose uptake and cooperates with glycolysis inhibitor to induce apoptosis in non-small cell lung carcinoma cells.
    Mi YJ; Geng GJ; Zou ZZ; Gao J; Luo XY; Liu Y; Li N; Li CL; Chen YQ; Yu XY; Jiang J
    PLoS One; 2015; 10(3):e0120426. PubMed ID: 25799586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Src Promotes Metastasis of Human Non-Small Cell Lung Cancer Cells through Fn14-Mediated NF-κB Signaling.
    Wang W; Liu F; Wang C; Wang C; Tang Y; Jiang Z
    Med Sci Monit; 2018 Mar; 24():1282-1294. PubMed ID: 29500337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis.
    Dong F; Zhou X; Li C; Yan S; Deng X; Cao Z; Li L; Tang B; Allen TD; Liu J
    Cancer Biol Ther; 2014; 15(11):1479-88. PubMed ID: 25482945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating network pharmacology and experimental models to investigate the mechanisms of dihydroartemisinin in preventing NSCLC progression via mTOR/HIF-1α signaling.
    Li Y; Xiao X; Wang H; Zhou Q; Jin Z; Zhang Y; Wang Y; Yue F; Zhou S; Yang J
    Eur J Pharmacol; 2021 Oct; 909():174411. PubMed ID: 34390710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of PMA-induced tumor cell invasion by dihydroartemisinin via inhibition of PKCalpha/Raf/MAPKs and NF-kappaB/AP-1-dependent mechanisms.
    Hwang YP; Yun HJ; Kim HG; Han EH; Lee GW; Jeong HG
    Biochem Pharmacol; 2010 Jun; 79(12):1714-26. PubMed ID: 20152819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/β-catenin signaling.
    Tong Y; Liu Y; Zheng H; Zheng L; Liu W; Wu J; Ou R; Zhang G; Li F; Hu M; Liu Z; Lu L
    Oncotarget; 2016 May; 7(21):31413-28. PubMed ID: 27119499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of onconase and dihydroartemisinin synergistically suppresses growth and angiogenesis of non-small-cell lung carcinoma and malignant mesothelioma.
    Shen R; Li J; Ye D; Wang Q; Fei J
    Acta Biochim Biophys Sin (Shanghai); 2016 Oct; 48(10):894-901. PubMed ID: 27590062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydroartemisinin and artesunate inhibit aerobic glycolysis via suppressing c-Myc signaling in non-small cell lung cancer.
    Zhang Y; Wang Y; Li Y; Huang C; Xiao X; Zhong Z; Tang J; Lu H; Tang Y; Yang J
    Biochem Pharmacol; 2022 Apr; 198():114941. PubMed ID: 35149053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo.
    Weng MC; Li MH; Chung JG; Liu YC; Wu JY; Hsu FT; Wang HE
    Biomed Pharmacother; 2019 Aug; 116():109032. PubMed ID: 31163381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G9a Promotes Invasion and Metastasis of Non-Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway.
    Sun T; Zhang K; Pangeni RP; Wu J; Li W; Du Y; Guo Y; Chaurasiya S; Arvanitis L; Raz DJ
    Mol Cancer Res; 2021 Mar; 19(3):429-440. PubMed ID: 33298547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydroartemisinin inhibits tumor progress via blocking ROR1-induced STAT3-activation in non-small cell lung cancer.
    Li Y; Sun H; Bai C; Hu Y; Tang J; Zhang Y; Chen J; Zhong Z; He Y; Hu K; Yang J
    Int Immunopharmacol; 2024 May; 133():112157. PubMed ID: 38678671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
    Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
    Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydroartemisinin and gefitinib synergistically inhibit NSCLC cell growth and promote apoptosis via the Akt/mTOR/STAT3 pathway.
    Jin H; Jiang AY; Wang H; Cao Y; Wu Y; Jiang XF
    Mol Med Rep; 2017 Sep; 16(3):3475-3481. PubMed ID: 28713965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin Inhibits the Proliferation and Metastasis of Human Non-Small Cell Lung Cancer Cell Line: The Key Role of Src-Mediated Fibroblast Growth Factor-Inducible 14 (Fn14)/ Nuclear Factor kappa B (NF-κB) pathway.
    Dong Y; Yang J; Yang L; Li P
    Med Sci Monit; 2020 Mar; 26():e920537. PubMed ID: 32225128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linarin inhibits radiation-induced cancer invasion by downregulating MMP-9 expression via the suppression of NF-κB activation in human non-small-cell lung cancer A549.
    Jung CH; Han AR; Chung HJ; Ha IH; Um HD
    Nat Prod Res; 2019 Dec; 33(24):3582-3586. PubMed ID: 29897257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases.
    Rasheed SA; Efferth T; Asangani IA; Allgayer H
    Int J Cancer; 2010 Sep; 127(6):1475-85. PubMed ID: 20232396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polydatin suppresses proliferation and metastasis of non-small cell lung cancer cells by inhibiting NLRP3 inflammasome activation via NF-κB pathway.
    Zou J; Yang Y; Yang Y; Liu X
    Biomed Pharmacother; 2018 Dec; 108():130-136. PubMed ID: 30218857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Id-1 promotes migration and invasion of non-small cell lung cancer cells through activating NF-κB signaling pathway.
    Li J; Li Y; Wang B; Ma Y; Chen P
    J Biomed Sci; 2017 Dec; 24(1):95. PubMed ID: 29233161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 promotes metastasis of non-small-cell lung cancer by up-regulating TIM-4 via NF-κB.
    Liu W; Wang H; Bai F; Ding L; Huang Y; Lu C; Chen S; Li C; Yue X; Liang X; Ma C; Xu L; Gao L
    Cell Prolif; 2020 Mar; 53(3):e12776. PubMed ID: 32020709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.